Red Book provides the latest pricing and product information on prescription and over-the-counter drug products within the industry, enabling healthcare professionals to quickly answer drug-related questions with information for 200,000+ prescription and over-the-counter drugs, nutraceuticals, and bulk chemicals.
The Red Book serves as a resource for drug utilization reviews, market analysis and research, prescription pricing, and order entry. It establishes and validates reimbursement, forecasting, drug-pricing research, generic substitution, therapeutic interchange, competitive analysis, purchasing, forumulary development and management, as well as claims adjudication, processing and validation.
FlutiCare is Innovus' nationally branded OTC fluticasone propionate nasal spray, USP 50 mcg per spray, which is indicated to treat individuals with allergic rhinitis.
UriVarx targets the bladder and surrounding tissues to promote normal urination and strong bladder tone, and is clinically proven in an 8-week double blind placebo controlled clinical trial in 150 patients to support bladder tone and function.
Innovus Pharma is engaged in the commercialisation, licensing, and development of safe and effective non-prescription medicine and consumer care products to improve men's and women's health and vitality, and respiratory diseases.
Apotex launches Teriparatide Injection in US
Teva Pharmaceuticals secures FDA approval for generic Forteo (teriparatide injection)
Upsher-Smith Laboratories introduces Pitavastatin Tablets
Par Pharmaceutical starts shipping colchicine 0.6mg capsules
Padagis launces Brinzolamide Ophthalmic Suspension with CGT exclusivity
Novartis completes Sandoz Spin-off
Novartis completes Sandoz spin-off, focusing on innovative medicines
Sanofi and Teva collaborate on innovative IBD treatment
Hikma marks KLOXXADO two-year anniversary by surpassing 375,000 doses donated in the US
STADA seeks full approval for Kinpeygo in IgA nephropathy from UK MHRA
Azurity Pharmaceuticals completes Slayback Pharma acquisition
Sandoz secures European approval for Tyruko biosimilar in MS treatment
Senores Pharmaceuticals introduces Nicardipine Hydrochloride Capsules USP, 20mg and 30mg in US
Lupin collaborates with Mark Cuban Cost Plus Drug Company and COPD foundation
Certara Simcyp receives FDA grants for advanced pharmacokinetic modelling